IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,831 | -4.8% | 6,000 | 0.0% | 0.00% | – |
| Q2 2023 | $6,125 | +1.9% | 6,000 | 0.0% | 0.00% | – |
| Q1 2023 | $6,012 | -8.1% | 6,000 | 0.0% | 0.00% | – |
| Q4 2022 | $6,544 | +9.1% | 6,000 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -14.3% | 6,000 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 40,225,000 | $40,854,000 | 1.37% |
| Wellesley Asset Management | 15,287 | $15,583,000 | 1.10% |
| SSI INVESTMENT MANAGEMENT LLC | 4,671,000 | $4,738,000 | 0.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,495,000 | $21,916,000 | 0.24% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,206,000 | $3,255,000 | 0.18% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,674,000 | $23,142,000 | 0.14% |
| AQR Arbitrage LLC | 4,100,000 | $4,185,000 | 0.09% |
| Polar Asset Management Partners Inc. | 7,000,000 | $7,164,000 | 0.09% |
| Calamos Advisors LLC | 9,500,000 | $9,722,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 7,105,000 | $7,216,000 | 0.01% |